Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis An International Multi-Institutional Analysis of 1669 Patients

被引:641
作者
de Jong, Mechteld C. [1 ]
Pulitano, Carlo [2 ]
Ribero, Dario [3 ]
Strub, Jennifer [4 ]
Mentha, Gilles [4 ]
Schulick, Richard D. [1 ]
Choti, Michael A. [1 ]
Aldrighetti, Luca [2 ]
Capussotti, Lorenzo [3 ]
Pawlik, Timothy M. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA
[2] Univ Milan, Osped San Raffaele, Dept Surg, I-20127 Milan, Italy
[3] Osped Mauriziano Umberto 1, Dept Surg, Turin, Italy
[4] Hop Cantonal Univ Geneva, Dept Surg, Geneva, Switzerland
关键词
HEPATIC RESECTION; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; PROGNOSTIC-FACTORS; CANCER; SURVIVAL; HEPATECTOMY; CARCINOMA; MARGIN; FAILURE;
D O I
10.1097/SLA.0b013e3181b4539b
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective(s): To investigate rates and patterns of recurrence in patients following curative intent surgery for colorectal liver metastasis. Background: Outcomes following surgical management of colorectal liver metastasis have largely focused on overall survival. Contemporary data on rates and patterns of recurrence following surgery for colorectal liver metastasis are limited. Methods: One thousand six hundred sixty-nine patients treated with surgery (resection +/- radiofirequency ablation [RFA]) for colorectal liver metastasis between 1982 and 2008 were identified from an international multi-institutional database. Clinicopathologic data, recurrence patterns, and recurrence-free survival (RFS) were analyzed. Results: At the time of the initial liver-directed surgery, surgical treatment was resection only (90.2%), resection plus RFA (8.0%), or RFA alone (1.8%). While 5-year overall survival was 47.3%, 947 (56.7%) patients recurred with a median RFS time of 16.3 months. First recurrence site was intrahepatic only (43.2%), extrahepatic only (35.8%), intra- and extrahepatic (21.0%). There was no difference in RFS based on site of recurrence (intrahepatic: 16.9 months; extrahepatic: 16.6 months; intra- and extrahepatic: 16.2 month; P > 0.05). Receipt of adjuvant chemotherapy was associated with overall recurrence risk (hazard ratio [HR] = 0.56), while history of RFA (HR = 2.39, P = 0.001) and RI margin status (HR = 1.36) were predictive of intrahepatic recurrence. Pattern of recurrence and RYS remained similar following repeat surgery for recurrent disease. Conclusions: While 5-year survival following surgery for colorectal liver metastasis approaches 50%, over one-half of patients develop recurrence within 2 years. The pattern of failure is distributed relatively equally among intrahepatic, extrahepatic, and intra-plus extrahepatic sites. Patients undergoing repeat surgery for recurrent metastasis have similar patterns of recurrence and RFS time.
引用
收藏
页码:440 / 448
页数:9
相关论文
共 41 条
[21]   RECURRENCE OF COLORECTAL-CANCER AFTER HEPATIC RESECTION [J].
FORTNER, JG .
AMERICAN JOURNAL OF SURGERY, 1988, 155 (03) :378-382
[22]   Colorectal Liver Metastases Recurrence and Survival Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection-Radiofrequency Ablation [J].
Gleisner, Ana L. ;
Choti, Michael A. ;
Assumpcao, Lia ;
Nathan, Hari ;
Schulick, Richard D. ;
Pawlik, Timothy M. .
ARCHIVES OF SURGERY, 2008, 143 (12) :1204-1212
[23]   HEPATIC RESECTION OF METASTASIS FROM COLORECTAL-CARCINOMA - MORBIDITY, MORTALITY, AND PATTERN OF RECURRENCE [J].
HOLM, A ;
BRADLEY, E ;
ALDRETE, JS .
ANNALS OF SURGERY, 1989, 209 (04) :428-434
[24]   Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among US Hispanic/Latino populations [J].
Howe, Holly L. ;
Wu, Xiaocheng ;
Ries, Lynn A. G. ;
Cokkinides, Vilma ;
Ahmed, Faruque ;
Jemal, Ahmedin ;
Miller, Barry ;
Williams, Melanie ;
Ward, Elizabeth ;
Wingo, Phyllis A. ;
Ramirez, Amelie ;
Edwards, Brenda K. .
CANCER, 2006, 107 (08) :1711-1742
[25]   RESECTION OF THE LIVER FOR COLORECTAL-CARCINOMA METASTASES - A MULTI-INSTITUTIONAL STUDY OF LONG-TERM SURVIVORS [J].
HUGHES, KS ;
ROSENSTEIN, RB ;
SONGHORABODI, S ;
ADSON, MA ;
ILSTRUP, DM ;
FORTNER, JG ;
MACLEAN, BJ ;
FOSTER, JH ;
DALY, JM ;
FITZHERBERT, D ;
SUGARBAKER, PH ;
IWATSUKI, S ;
STARZL, T ;
RAMMING, KP ;
LONGMIRE, WP ;
OTOOLE, K ;
PETRELLI, NJ ;
HERRERA, L ;
CADY, B ;
MCDERMOTT, W ;
NIMS, T ;
ENKER, WE ;
COPPA, GF ;
BLUMGART, LH ;
BRADPIECE, H ;
URIST, M ;
ALDRETE, JS ;
SCHLAG, P ;
HOHENBERGER, P ;
STEELE, G ;
HODGSON, WJ ;
HARDY, TG ;
HARBORA, D ;
MCPHERSON, TA ;
LIM, C ;
DILLON, D ;
HAPP, R ;
RIPEPI, P ;
VILLELLA, E ;
SMITH, W ;
ROSSI, RL ;
REMINE, SG ;
OSTER, M ;
CONNOLLY, DP ;
ABRAMS, J ;
ALJURF, A ;
HOBBS, KEF ;
LI, MKW ;
HOWARD, T ;
LEE, E .
DISEASES OF THE COLON & RECTUM, 1988, 31 (01) :1-4
[26]   HEPATIC RESECTION FOR METASTASES FROM COLORECTAL-CARCINOMA - A SURVIVAL ANALYSIS [J].
JATZKO, GR ;
LISBORG, PH ;
STETTNER, HM ;
KLIMPFINGER, MH .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (01) :41-46
[27]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[28]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[29]   Drug therapy - Systemic therapy for colorectal cancer [J].
Meyerhardt, JA ;
Mayer, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (05) :476-487
[30]   Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience [J].
Nuzzo, Gennaro ;
Giuliante, Felice ;
Ardito, Francesco ;
Vellone, Mairia ;
Giovannini, Ivo ;
Federico, Bruno ;
Vecchio, Fabio M. .
SURGERY, 2008, 143 (03) :384-393